Stellate Ganglion Block in Patients With Advanced Primary Parkinson's Disease: a Small, Open, Randomized Controlled Clinical Study
At present, there are no reports on the application of stellate ganglion block in the treatment of Parkinson's disease patients at home and abroad. Based on the preliminary clinical observation, this project intends to apply stellate ganglion block in the treatment of patients with intermediate and advanced Parkinson's disease through an open, randomized controlled small sample clinical study. To determine whether stellate ganglion block can effectively improve motor symptoms and non-motor symptoms in patients with primary advanced Parkinson's disease.
⁃ Patients with Parkinson's disease who met the diagnostic criteria for MDS as probable PD or confirmed PD in 2016
‣ Age 40-85;
‣ Patients with Parkinson's disease who met the diagnostic criteria of MDS as probable PD or confirmed PD in 2016;
‣ The patient or his/her legal guardian agrees to participate in the study and signs the informed consent;
‣ Hoehn-yahr (H\&Y) 2.5 \
• 5;